FTSE 100 stocks dragged lower by miners and copper price drop shock
The FTSE 100 was down 32 points to 7,342 shortly after 3.15pm on Monday
Company
Futura Medical PLC
LON:FUM
Futura Medical specialises in the development and global commercialisation of innovative sexual health products, including lead product Eroxon®. The company's core strength lies in its research, development and commercialisation of topically delivered gel formulations in sexual health products.
303 stories · page 14 of 16
Archive
Proactive news round-up: H&T Group, Akers Biosciences, LGO Energy ...
A glance at some of the stories on the Proactive newswire today.
Futura Medical inks pain relief deal
The deal is with German group STADA, which owns Huddersfield-based Thornton & Ross.
Archive
Proactive news round-up: Futura Medical , Gfinity, Sound Energy ...
A glance at some of the stories on the Proactive newswire today
Futura's erectogenic condom launched in Saudi Arabia
The condoms will be marketed under the brand name Futura Max Manex Super.
Futura Medical: Octopus Investments lifts stake
Octopus now holds around 9.6 mln voting rights or 8.01% following the transaction.
Immupharma among the small cap pharmas in focus on Wednesday
Immupharma among the small cap pharmas in focus on Wednesday, alongside Futura Medical, Horizon Discovery Group, and Summit Therapeutics.
Futura’s ED treatment ‘more effective than first thought’
The company’s erectile dysfunction treatment can take as little as 60 seconds to have an effect
Futura Medical unveils twin strategy for flagship drug alongside new head of R&D
Futura said it has recruited Ken James, currently a non-executive director, to oversee its research and development efforts.
Proactive news summary: Arian Silver Corp, Diamondcorp, eg Solutions, Futura Medical, Strategic Minerals, Stobart Group, Versarien
On the day Misys called off its planned flotation, Futura and Strategic Minerals found willing buyers for their shares.
Futura Medical unveils plans to raise £12mln
“The placing is expected to allow the group to continue to fund additional product and commercial development activities and to seek additional licence agreements on more favourable terms than would otherwise be available,” the company said
Ready to go again? Futura Medical tipped to rally
The dust has settled after August's 300% rally, but technical analysis suggests the price will move higher again.
Futura Medical price has doubled, but is this just the beginning?
There is an argument, based on the company’s own research, that the current share price barely scratches the surface.
Futura Medical says shelf-life issue with condoms have been resolved
The CSD500 condom is close to regulatory approval for a longer shelf life and partner launch.
Risers and fallers: Sportech, JD Sports and Corero Network Security
Sportech is selling off The Football Pools to a group of gambling industry investors for nearly £100mln
UK stocks end higher as tech sector lights up with merger deal, oil prices rise
London shares closed higher on Thursday led by Britain’s biggest tech deal of the year and an advance by oil prices
Futura shares double after successful clinical trial
It means Futura now has a differentiated product in a market worth US$5bn that , currently dominated by top-selling drugs, such as Viagra and Cialis, that have limitations.
Risers and fallers, including Futura Medical and Windar Photonics
A look at some of today’s significant movers in London
Futura Medical trial success provides key to US$5bn drugs market
The study of 232 men successfully demonstrated MED2002’s efficacy, safety and speed of onset.